Image: Popular podcast host Joe Rogan tested positive for COVID-19 but quickly received ivermectin treatment and continued his exercise routine. Within 24 hours, Rogan, who has not received the COVID-19 vaccine, had no symptoms of the disease.
Boulder (Colorado) and Washington, D.C. – Popular podcast host Joe Rogan announced on his show on Wednesday, September 1, 2021, that he tested positive for COVID-19, also known as the China Virus. Rogan has discussed his unwillingness to take the COVID-19 vaccines, which the political leadership in Washington, D.C., has pushed as a result of its close relationship with Big Pharma manufacturers.
Rogan has a daily exercise regimen, which he didn’t stop when he became sick. He had the symptoms of the disease for approximately twenty-four (24) hours. Rogan used a multitude of medications and treatments, such as monoclonal antibodies, ivermectin, the steroid prednisone, an antibiotic Z-Pak, and a vitamin drip.
Within a day, Rogan’s symptoms went away and he no longer feels sick.
If you’re wondering why health care providers, such as university faculties, hospitals, and even private medical clinics so militantly follow the pronouncements of the National Institutes of Health (NIH) and the Centers for Disease Control (CDC) rather than providing treatment protocols for COVID-19, you need look no further than the Public Readiness and Emergency Preparedness Act (PREP Act), which Congress passed and President George W. Bush signed into law in 2005. PREP Act provides tort immunity in certain instances after the Secretary of Health and Human Services has declared a “public health emergency.”
Immunity means that courts must dismiss claims brought against any entity or individual covered by the PREP Act. Claims that courts must dismiss include claims for any loss that is related to any stage of design, development, testing, manufacture, labeling, distribution, formulation, labeling, packaging, marketing, promotion, sale, purchase, donation, dispensing, prescribing, administration, licensing or use of a countermeasure recommended in a Declaration. This includes, but is not limited to, claims for:
- physical, mental, or emotional injury, illness, disability, or condition or fear of any such injury, illness, disability, or condition;
- any need for medical monitoring; or
- property damage or loss, including business interruption loss.
On January 31, 2020, the former Secretary of Health and Human Services, Alex M. Azar II, declared a “public health emergency,” effective January 27, 2020, for the entire United States to aid in the response of the nation’s health care community to the COVID–19 outbreak. That Declaration has had eight (8) amendments. Basically, it comes down to the following “covered countermeasures” for COVID-19:
“Covered Countermeasures are
“(1) any antiviral, any other drug, any biologic, any diagnostic, any other device, any respiratory protective device, or any vaccine, used
“a. to treat, diagnose, cure, prevent, mitigate or limit the harm from COVID-19, or the transmission of SARS-CoV-2 or a virus mutating therefrom, or
“b. to limit the harm that COVID-19, or the transmission of SARS-CoV-2 or a virus mutating therefrom, might otherwise cause; or
“(2) any device used in the administration of any such product, and all components and constituent materials of any such product.
“Covered Countermeasures must be ‘qualified pandemic or epidemic products,’ or ‘security countermeasures,’ or drugs, biological products, or devices authorized for investigational or emergency use, as those terms are defined in the PREP Act, the FD&C Act, and the Public Health Service Act, or a respiratory protective device approved by NIOSH under42 CFR part 84, or any successor regulations, that the Secretary determines to be a priority for use during a public health emergency declared under section 319 of the PHS Act.”
The problem, however, is that only the vaccines and a very limited number of drugs, the vaccines, as well as ventilator treatments, have received approval from the Food and Drug Administration, the NIH, and the CDC for the treatment of COVID-19. Ivermectin, the winner of the 2015 Nobel Prize in Physiology and Medicine, is not an approved drug for treatment of COVID-19 under the PREP Act regulations, so hospitals do not receive PREP Act immunity, if they allow treatments by ivermectin.
This newspaper has confirmed that nurses and health care providers who work in COVID-19 treatment wards in numerous hospitals around the United States treat themselves with ivermectin, even though the hospitals for which they work refuse to recognize the Nobel-Prize-winning drug as proper treatment for the disease.
In other words, the United States government directly controls your medical care and the treatments for COVID-19 you may receive in hospitals and other health care providing institutions.